Project Number 1U01NS119560-01 Agency/Funding Organization NINDS Funding Year 2021 View Full Project Details for Humanization of a Notch 3 agonist antibody for pre-clinical development of a CADASIL treatment Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 11. Vascular Etiology a. Cardiovascular and Cerebrovascular dysfunction Researcher and Organization Principal Investigator ARBOLEDA-VELASQUEZ, JOSEPH Principal Investigator First Name JOSEPH Principal Investigator Last Name ARBOLEDA-VELASQUEZ Awardee Organization SCHEPENS EYE RESEARCH INSTITUTE Awardee State Massachusetts Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-17-456: NINDS CREATE Bio Optimization Track for Biologics (U01) FY Overall Cost $729,401 Funding Organization Agency/Funding Organization NINDS Funding Organization Country United States Program Official BOSHOFF, CHRIS
